Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,749 public trials 1,058 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130

Conditions
Advanced or Metastatic Solid Tumors, Brain Diseases, Brain Neoplasms, +41 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Phase I Clinical Trials Unit Birmingham, Alabama, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

NCT07586124

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations
  • Kaiser Permanente-Division of Research Pleasanton, California, United States
  • Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
  • Kaiser Permanente-Franklin Denver, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 39 locations
View Trial Details
Recruiting

Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

NCT07686575

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +9 more
Locations
  • Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou Guangzhou, Guangdong, China
  • Department of Stomatology, Zhujiang Hospital, Southern Medical University,Haizhu District Guangzhou, Guangdong, China
View Trial Details

Related conditions